Brandi Roberts

This profile gathers the share dealings of Brandi Roberts across 5 companies, led by Definium Therapeutics, Inc., REVA Medical, Inc. and TFF Pharmaceuticals, Inc. Over a trading history stretching from 22 January 2018 to 25 September 2026, the count stands at 12 filings.

The open-market side counts 3 purchases for €16k alongside 2 sales for €228k. Taken together, the sales exceed the purchases by €212k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 7 share grants. In 2026 alone, the filings show no purchases and 2 sales.

Half of the purchases are above €4,585 and half below. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

On 29 September 2026 came the latest disclosure, an open-market sale for €109k in Definium Therapeutics, Inc. The clock since the last published purchase (15 August 2023) now reads 1,166 days. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.